{{Rsnum
|rsid=2710646
|Gene=EHBP1
|Chromosome=2
|position=62907744
|Orientation=plus
|GMAF=0.1088
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;C)
|geno3=(C;C)
|Gene_s=EHBP1
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;C)
| geno3=(C;C)
| CEU | 0.9 | 25.7 | 73.5
| HCB | 0.0 | 5.1 | 94.9
| JPT | 0.9 | 12.4 | 86.7
| YRI | 0.0 | 0.0 | 100.0
| ASW | 0.0 | 12.3 | 87.7
| CHB | 0.0 | 5.1 | 94.9
| CHD | 0.0 | 5.5 | 94.5
| GIH | 2.0 | 20.8 | 77.2
| LWK | 0.0 | 4.5 | 95.5
| MEX | 1.7 | 27.6 | 70.7
| MKK | 0.6 | 20.5 | 78.8
| TSI | 2.0 | 23.5 | 74.5
| HapMapRevision=28
}}
rs2710646(A) had an OR of 1.16 (P = 7.79x10-4) for all Icelandic [[prostate cancer]] cases

{{PMID Auto
|PMID=18974127
|Title=Association study of prostate cancer susceptibility variants with risks of invasive ovarian, breast, and colorectal cancer.
|OA=1
}}

{{PMID Auto
|PMID=20690139
|Title=Meta-analysis of genome-wide and replication association studies on prostate cancer.
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}